Authors
Latest:
Fibromyalgia Classification, Triggers, and EtiologyOur evolving understanding of the potential causes of fibromyalgia, and its placement along a continuum of related conditions, informs an individualized treatment approach.
Latest:
Reconsidering Digoxin in Worsening Chronic Heart FailureShould we give digoxin another look for chronic heart failure?
Latest:
Benefits and Drawbacks of Clopidogrel 600mg Double Loading Dose Versus Newer P2Y12 Receptor BlockersProlonged dual antiplatelet therapy With aspirin and clopidogrel is recommended for all patients undergoing percutaneous coronary intervention.
Latest:
C. Diff Foundation Highlights Latest Advances in the Battle Against the Deadly PathogenCDC official is hopeful they can beat C diff infection.
Latest:
Are HDL cholesterol levels clinically significant in patients with low LDL cholesterol levels?There is some debate about whether the risk of cardiovascular events associated with low high-density lipoprotein (HDL) cholesterol levels is attenuated by very low low-density lipoprotein (LDL) cholesterol levels (< 60 mg/dL), which can be obtained with statins and combination therapy.
Latest:
Combination antithrombotic and antiplatelet therapy for preventing thromboembolic complications in patients with atrial fibrillationFew medical treatment goals are more important yet more troublesome than the prevention of thromboembolic complications in patients with atrial fibrillation (AF).
Latest:
Morphine Decreases Clopidogrel Concentrations and EffectsIs there a clinically significant interaction between morphine and clopidogrel?
Latest:
Are Your Patients in Clinical Trials? US Oncology Surveys OncologistsParticipation in clinical trial research is essential to continued improvement in cancer care. Yet, fewer than 10% of U.S. adults enroll in trials. A recent US Oncology�sponsored survey found that most oncologists remain optimistic about the future of clinical trial research. We discuss obstacles to clinical trial enrollment with Nicholas Vogelzang, MD, and Matthew Galsky, MD, of the Comprehensive CancerCenters of Nevada.
Latest:
High-resolution spiral computed tomography coronary angiographyWe evaluated the performance of the 64-slice spiral computed tomography coronary angiography scanner in 52 symptomatic patients with stable sinus rhythm and found that it was highly reliable in ruling out the presence of a significant coronary stenosis. This technique may be regarded as a suitable alternative to invasive coronary angiography.
Latest:
How GSSI, A Nonprofit, is Fighting GastroparesisPatrick Dunegan, Rare Impact Awardee, explains how GSSSI, a 501c3 nonprofit organization, is working to fight gastroparesis, a gastric motility disorder known to be very debilitating for those who suffer from it.
Latest:
How Would You Manage This Man With Non-alcoholic Fatty Liver DiseaseYou see a 48-year-old white man for his annual examination. He is in good health with no major medical problems and an unremarkable medical history. He states he regularly drinks one or two beers a day on the weekend but not usually on weekdays. He denies blood transfusions, tattoos or intravenous drugs. His father had diabetes. Physical examination is notable for the patient being mildly obese with a body mass index of 32.
Latest:
Alternating Hemiplegia of Childhood: Partnering with the PatientSince AHC is a rare neurological disease, finding a diagnosis can be a harrowing experience.
Latest:
Healthcare "Game Changers" at the 2011 Consumer Electronics ShowBuzz at the CES has focused on smartphones, 3-D TVs, and new tablets, but companies are unveiling game changing technologies in health care.
Latest:
Improving Your Patients' Adherence to Statin TherapyDespite the proven benefits of lipid-lowering therapy, many patients stop taking their prescribed medications. Follow these practical tips to increase patients' compliance.
Latest:
Significance of hyperglycemia and platelet function in diabetic patientsGlucose-insulin-potassium (GIK) was initially advocated as a treatment of acute myocardial infarction (MI) to promote electrical stability.
Latest:
Glaucoma: The Silent Killer of EyesightGlaucoma is a leading cause of blindness in the United States. The 2 main types of glaucoma are open-angle and narrow-angle. Glaucoma damages the optic nerve, typically resulting in loss of peripheral vision, which eventually progresses to involve the central visual field. Because patients with glaucoma are usually asymptomatic, primary care physicians can play a vital role in recognizing this silent cause of blindness. The goal of treatment, which consists of eye drops, laser trabeculoplasty, or surgery, is to lower intraocular pressure. Eye drops are effective but can have local as well as systemic side effects. Early recognition in the primary care setting and timely referral to ophthalmologists can prevent permanent vision loss.
Latest:
Insight into a Forgotten Disease: Lemierre's SyndromeLemierre's syndrome is characterized by oropharyngeal infection, usually by Fusobacterium necrophorum, followed by septic thrombophlebitis of the internal jugular vein with embolization to the lungs and other organs. Since the introduction of antibiotics, Lemierre's syndrome has become relatively rare and is usually unsuspected until blood culture results are available. In the preantibiotic era, ligation of the internal jugular vein on the affected side to prevent septicemia was the only recognized treatment. Current therapy is a 4- to 6-week course of antibiotics, such as penicillin G, clindamycin, or metronidazole, directed against F necrophorum. The use of anticoagulation is still controversial.
Latest:
Clinical Decision Support: Information overload can be a prescription for bad medicineThe push for clinical decision support technology in medicine is a logical consequence of our experiences.
Latest:
Medical Ethics and the Amish Bus Driver RuleIn which the author expounds upon the dangers posed by Progressive medical ethics.
